There has been a substantial increase in recent years in the use of a form of primary medication to treat opioid use disorder ...

The use of medication for opioid use disorder (MOUD) in older adults has increased over the years, yet disparities persist across patient subgroups, with men, Black and Hispanic individuals, rural ...

Individuals with opioid use disorder can get “stuck” in particular patterns of brain activity, a new Yale study finds. And this stickiness is more pronounced after they’ve seen images related to ...

Long-acting injectable adoption remains low, but Indivior's market position, payer access and consumer campaign could help ...

An updated evidence-based guideline aimed at helping clinicians and other health care providers manage patients with opioid use disorder recommends buprenorphine and methadone as first-line treatments ...

Semaglutide (Ozempic, Novo Nordisk) is associated with a significantly lower risk for overdose in individuals with opioid use disorder (OUD), new research shows. The findings suggest that the drug may ...

Delaware hospitals are adopting a new statewide approach to treating opioid use disorder in emergency departments, with ...

The US Food and Drug Administration approved a novel tool Tuesday that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder. The AutoGenomics AvertD ...

Among 2.5 million adults with opioid use disorder (OUD), only 36% received any substance use treatment, and only 22% received medications for OUD in a recent study. In 2021, an estimated 2.5 million ...

Achieving opioid pharmacoequity or ensuring access to evidence-based pharmacologic therapies regardless of race and ethnicity is a pressing issue in cancer care. 7 This commentary focuses on the role ...

The move would place the products in the same category as heroin and LSD.

There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, ...